Andrea Fagiolini, MD

Dipartimento di Medicina Molecolare e dello Sviluppo, Dipartimento di Psichiatria, University of Siena, Siena, Italy

PCC
Vortioxetine Supratherapeutic Dosing in TRD
Original Research

June 9, 2022

This study evaluated the effectiveness and tolerability of vortioxetine at supratherapeutic dosages in patients with treatment-resistant depression.
Alessandro Cuomo, Aurora Santucci, Marco Chioccioli, et al
JCP
Original Research

June 2, 2020

Read a study examining predictors of switch to depression in bipolar patients who started or changed treatment for mania or mixed-mania.
Giuseppe Maccariello, Margherita Barbuti, Giulia Vannucchi, et al
JCP
Commentary

March 31, 2020

In this commentary, the authors describe the hospital environment and the protective measures being taken during the COVID-19 pandemic in a hospital in Tuscany, Italy.
Andrea Fagiolini, Alessandro Cuomo, Ellen Frank
JCP
ASCP Corner

December 15, 2012

Holly A. Swartz, Andrea Fagiolini
JCP
Article

January 15, 2012

Read a report distinguishing the role of psychomotor activation in discriminating unipolar from bipolar disorders.
Giovanni B. Cassano, Paola Rucci, Antonella Benvenuti, et al
JCP
Article

June 25, 2009

Andrea Fagiolini, Arianna Goracci
JCP
Original Research

December 31, 2008

Sara B. Fleet-Michaliszyn, Isabella Soreca, Amy D. Otto, et al
JCP
Article

August 31, 2008

Virginio Salvi, Andrea Fagiolini, Holly A. Swartz, et al
JCP
Educational Activity

June 30, 2008

Andrea Fagiolini
JCP
Letter to the Editor

March 18, 2008

Andrea Fagiolini, Ellen Frank, Scott Turkin, et al
JCP
Original Research

June 15, 2006

Jennifer E. Wildes, Marsha D. Marcus, Andrea Fagiolini
JCP
Original Research

May 15, 2006

Wesley K. Thompson, David J. Kupfer, Andrea Fagiolini, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe